Imagine a common gut bacterium spreading as swiftly as a global flu pandemic—sounds alarming, right? New research reveals that certain strains of E. coli can transmit as rapidly as swine flu, despite not being airborne. But here’s where it gets even more intriguing: scientists have, for the first time, calculated the transmission rate of gut bacteria between individuals—a feat previously reserved for viruses. This groundbreaking study, published in Nature Communications, sheds light on how E. coli strains, some resistant to multiple antibiotics, move through populations, particularly in healthcare settings.
Researchers from the Wellcome Sanger Institute, the University of Oslo, the University of Helsinki, and Aalto University collaborated to analyze three major E. coli strains in the UK and Norway. Two of these strains are notorious for causing urinary tract and bloodstream infections, often resistant to common antibiotics. By using advanced modeling techniques, the team discovered that one strain, ST131-A, spreads as quickly as viruses like swine flu (H1N1), even though E. coli isn’t airborne. Meanwhile, two other antibiotic-resistant strains, ST131-C1 and ST131-C2, spread slowly among healthy individuals but pose a significant risk in hospitals and healthcare facilities.
But here’s the controversial part: Could hospitals unknowingly become hotspots for these antibiotic-resistant strains? The study highlights the urgent need to track and control such bacteria more effectively, especially as antibiotic resistance continues to rise globally. In the UK alone, over 40% of E. coli bloodstream infections resist key antibiotics, making this research timely and critical.
The scientists employed a novel inference software called ELFI to predict the basic reproduction number (R0) for these strains—a metric traditionally used for viruses. This approach not only helps predict infection spread but also identifies high-risk strains, informing public health strategies to protect vulnerable populations. For instance, understanding the genetic mechanisms behind E. coli’s rapid spread could lead to targeted treatments, reducing reliance on broad-spectrum antibiotics.
E. coli is a double-edged sword: while most strains are harmless gut residents, others can cause life-threatening sepsis if they enter the bloodstream, particularly in immunocompromised individuals. The study’s findings underscore the importance of early detection and prevention, especially in healthcare settings where these strains thrive.
And this is the part most people miss: The techniques developed here aren’t limited to E. coli. They can be adapted to other bacterial pathogens, potentially revolutionizing how we combat invasive infections globally. As Fanni Ojala, co-first author of the study, notes, “This model opens doors to understanding, tracking, and preventing the spread of antibiotic-resistant infections across various bacterial strains.”
Dr. Trevor Lawley, who co-led the UK Baby Biome Study, emphasizes the significance of such research: “Understanding how bacteria shape our health starts with knowing where we begin. Studies like these provide invaluable insights that could benefit us all.”
Professor Jukka Corander adds, “With R0, we can now compare bacterial spread to viral infections more clearly. Identifying the genetic drivers behind rapid transmission could lead to innovative diagnostic and treatment methods, especially for antibiotic-resistant strains.”
But here’s the question for you: As antibiotic resistance grows, should healthcare systems prioritize tracking and controlling bacterial transmission over developing new antibiotics? Share your thoughts in the comments—this debate is far from over.
Reference: Ojala F, Pesonen H, Gladstone RA, et al. Basic reproduction number varies markedly between closely related pandemic Escherichia coli clones. Nat Commun. 2025;16(1):9490. doi:10.1038/s41467-025-65301-1
This article is republished from [source link], with edits for clarity and length. For more details, contact the original source. Our republishing policy is available [here].
